AnteoTech Ltd ADO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.02
- Day Range
- A$0.02–0.02
- 52-Week Range
- A$0.02–0.06
- Bid/Ask
- A$0.02 / A$0.02
- Market Cap
- A$55.39 Mil
- Volume/Avg
- 99,301 / 2.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 111.11
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its keys areas are Energy and Life Science Division. The company is developing four products named AnteoCoat, AnteoX, AnteoBind, and AnteoRelease, all of these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the Anteo Intellectual property.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 99
- Website
- https://www.anteotech.com
Comparables
Valuation
|
Metric
|
ADO
|
688468
|
000710
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 19.40 | — |
Price/Book Value | 10.63 | 2.01 | 1.20 |
Price/Sales | 111.11 | 6.00 | 1.91 |
Price/Cash Flow | — | 15.87 | 41.34 |
Price/Earnings
ADO
688468
000710
Financial Strength
|
Metric
|
ADO
|
688468
|
000710
|
|---|---|---|---|
Quick Ratio | 2.79 | 4.85 | — |
Current Ratio | 2.90 | 5.74 | — |
Interest Coverage | — | 644.72 | — |
Quick Ratio
ADO
688468
000710
Profitability
|
Metric
|
ADO
|
688468
|
000710
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.84% | −8.35% |
Return on Equity (Normalized) | — | 9.23% | −11.64% |
Return on Invested Capital (Normalized) | — | 8.57% | −10.02% |
Return on Assets
ADO
688468
000710
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Xlfnxjmf | Tbyt | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Myqbwlq | Dlmzws | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Fglldsjc | Yzvnszm | $99.5 Bil | |
MRNA
| Moderna Inc | Kfzsxrzw | Hylqr | $38.8 Bil | |
ARGX
| argenx SE ADR | Zcwcljlk | Hqvc | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Hfzvqfn | Ytfd | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Bxphjvrs | Tfvpl | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Xsxpwtb | Cbkjq | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Trzmyhbvb | Wqhbqq | $12.5 Bil | |
INCY
| Incyte Corp | Ndbnckfy | Tmqpkfx | $11.6 Bil |